Related Experiment Video
Updated: Aug 16, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Progress of cGAS-STING signaling in response to SARS-CoV-2 infection
Yaru Wu1, Min Zhang2, Cui Yuan1
1College of Life Sciences, Henan Agricultural University, Zhengzhou, China.
Abstract:
Coronavirus disease 2019 (COVID-19) is an epidemic respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can cause infections in millions of individuals, who can develop lung injury, organ failure, and subsequent death. As the first line of host defense, the innate immune system is involved in initiating the immune response to SARS-CoV-2 infection and the hyperinflammatory phenotype of COVID-19. However, the interplay between SARS-CoV-2 and host innate immunity is not yet well understood. It had become known that the cGAS-STING pathway is involved in the detection of cytosolic DNA, which elicits an innate immune response involving a robust type I interferon response against viral and bacterial infections. Nevertheless, several lines of evidence indicate that SARS-CoV-2, a single-stranded positive-sense RNA virus, triggered the cGAS-STING signaling pathway. Therefore, understanding the molecular and cellular details of cGAS-STING signaling upon SARS-CoV-2 infection is of considerable biomedical importance. In this review, we discuss the role of cGAS-STING signaling in SARS-CoV-2 infection and summarize the potential therapeutics of STING agonists as virus vaccine adjuvants.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection triggers the cGAS-STING pathway, a key part of innate immunity. Understanding this interaction is vital for developing new COVID-19 therapies and vaccine adjuvants.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, leads to severe respiratory illness and can result in organ failure and death.
- The innate immune system, including the cGAS-STING pathway, plays a crucial role in responding to viral infections like SARS-CoV-2.
- The precise mechanisms by which SARS-CoV-2 interacts with and potentially triggers the cGAS-STING pathway remain incompletely understood.
Purpose of the Study:
- To elucidate the role and molecular details of the cGAS-STING signaling pathway in the context of SARS-CoV-2 infection.
- To explore the potential of STING agonists as therapeutic agents and vaccine adjuvants for COVID-19.
Main Methods:
- This review synthesizes existing research on the innate immune response to SARS-CoV-2.
- It specifically examines evidence linking SARS-CoV-2 infection to the activation of the cGAS-STING pathway.
- The review discusses the implications of this pathway activation for disease pathogenesis and therapeutic strategies.
Main Results:
- Evidence suggests that SARS-CoV-2, despite being an RNA virus, can activate the DNA-sensing cGAS-STING pathway.
- This activation is a significant aspect of the host's innate immune response to the virus.
- Understanding this interplay is critical for comprehending COVID-19's hyperinflammatory aspects.
Conclusions:
- The cGAS-STING pathway is implicated in the innate immune response to SARS-CoV-2.
- Further research into the molecular mechanisms of cGAS-STING activation by SARS-CoV-2 is warranted.
- STING agonists represent a promising therapeutic avenue for COVID-19 treatment and vaccine enhancement.
More Related Videos
09:25Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
Published on: August 19, 2016
07:26Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli
Published on: December 26, 2020
Related Concept Videos
Stress Response System
Alarm stage
In the alarm stage, the body's...
GPCRs Regulate Adenylyl Cylase Activity
Intracellular Signaling Cascades
The JAK-STAT Signaling Pathway